Levetstad 500 Stella Treatment of localities (3 blisters x 10 tablets)

Dosage form Box of 3 blisters x 10 tablets
Specifications Levetiracetam

Ingredient

Composition informationContent
Levetiracetam500mg

Uses

indications

Levetstad drugs are indicated in the following cases:

Affairs

Treatment of local boundary onset epilepsy or not accompanied by secondary comprehensive comprehensive complexity in patients aged 16 and older has just been diagnosed with epilepsy.

Coordination treatment

  • In the treatment of local bundled epilepsy or not accompanied by secondary comprehensive comprehensive generalization in adults and children aged 12 and older epilepsy.

    Pharmacology

    levetiracetam is the derivative of pyrrolidone (the S isomers of Alpha-Ethyl-2-OxO-1- Pyrrolidine Acetamide), which are not related to existing anti-epileptic drugs. Levetiracetam prevents epilepsy on a wide range with a local epilepsy model and the whole rawemization on animals without affecting the tendency to cause seizures. Main metabolites are not active.

    In humans, the impact on both local epilepsy and all -transparent chemistry (epilepsy/dramatic discharge caused by light) has proved the broad -spectral pharmacological effect of levetiracetam.

    Pharmacokinetics

    absorption

    Levetiracetam is easily absorbed through the gastrointestinal tract with nearly 100%bioavailability. The peak concentration of plasma is achieved after drinking about 1.3 hours and reaching a stable state after 2 days.

    Distribution

    The ratio of cohesion with plasma proteins is very small, less than 10%. Levetiracetam is excreted through breast milk.

    Metabolism

    levetiracetam is not much metabolized. About 25% of oral doses are hydroxylated into non -active metabolites.

    Elimination

    About 95% of oral dose is eliminated in a constant form and metabolites in urine. Selling duration of plasma in adults and children 12 years and older is about 7 hours, in children younger than the selling time may shorter.

  • Before taking Levetstad 500 Stella Treatment of localities (3 blisters x 10 tablets)

    How to use

    oral medication with a sufficient amount of water and can be taken during or outside meals.

    Dosage

    Unit

    Patients aged 16 and older: The starting dose of 250 mg 2 times/day and increased to 500 mg 2 times/day after 2 weeks. This dose may continue to increase by 250 mg x 2 times/day every 2 weeks depending on the clinical response. The maximum dose of 1500 mg x 2 times/day.

    Coordination treatment

    Adults (≥ 18 years old) and adolescents (12-17 years old) weighs ≥ 50 kg: The starting dose of 500 mg x 2 times/day. Depending on the clinical response and tolerance capacity, can increase to 1500 mg 2 times/day. Can add 500 mg x 2 times/day every 2-4 weeks.

    Patients ≥ 65 years old and patients with renal function: Daily dose is adjusted by renal function.

    Creatinine clearance (ml/min)

    Dosage (mg)

    The distance between 2 doses (hours)

    80

    500–1500

    12

    50–79

    500–1000

    12

    30–49

    250–750

    12

    250–500

    12

    500–1000

    24 (*)

    Patients with liver failure: No dose adjustment for patients with mild to moderate liver failure. For patients with severe liver failure, creatinine clearance may not fully assess the level of renal failure. Therefore, 50% of the daily maintenance dose should be reduced when creatinine clearance

    Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What to do when overdose?

    There is no specific antidote for levetiracetam. The main dose treatment is mainly symptomatic treatment and can be hemoglobin. The fertilizer efficiency is about 60% for levetiracetam and 74% for the main metabolites.

    What to do when you forget a dose? However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Note that it should not be used double the prescribed dose.

    Side Effects

    When using Levetstad, you may experience unwanted effects (ADR).

    Common, ADR> 1/100

  • Infection and parasitic infection: Nasomy throat. face.
  • blood and lymph: platelet reduction, leukemia. Feeling, concentrated disorders. Meet, 1/10000
  • Infection and parasitic infection: infection. liver.

    When experiencing side effects of the drug, it is necessary to stop using and notify the doctor or go to the nearest medical facility for timely treatment.

  • Warnings

    Before using the drug you need to read the instructions carefully and refer to the information below.

    contraindicated

    Levetstad drugs contraindicated in the following case:

    Hypersensitivity to levetiracetam, other substances of pyrrolidone or any other ingredient of the drug.

    Be cautious when used

    Stop drugs: Do not stop the drug suddenly to avoid the risk of increasing seizures. When stopping the drug, levetiracetam should be reduced gradually by 1 g/day, about 2 weeks away.

    Patients with renal failure: adjust the dose by renal function.

    The suicide trend: suicide, trying to commit suicide or intended to be observed by suicide in patients using anti -epileptic drugs.

    The ability to drive and operate machinery

    There has been no research on the effect of the drug on the ability to drive and operate machinery. Because sensitivity per individual may vary, some patients may be sleepy or have other symptoms related to the central nervous system, especially when they start treatment or after increasing the dose. Therefore, it is necessary to be cautious for patients when performing jobs that require skills such as driving and operating machinery. Patients should not drive or operate machinery until sure the drug does not affect these activities.

    Pregnancy

    There are no adequate and controlled studies on pregnant women. Animal studies have shown that Levetiracetam has a development of toxicity. Therefore, levetiracetam should only be used for pregnant women when the benefits bring higher risk to the potential for the fetus.

    breastfeeding period

    levetiracetam is excreted through breast milk. Due to the potential harmful reactions on breastfed babies, it is necessary to consider the importance of the drug for the mother when deciding to stop the drug or stop breastfeeding.

    Drug interaction

    There is no clinical significant pharmacy interaction with other anti -epileptic drugs (such as Carbamazepine, Gabapentin, Lamotrigine, Phenobarbital, Phenytoin, Primidone, Valproic Acid). In young children, Levetiracetam clearance increases 22% when used simultaneously with anti -epilepsy drugs that cause liver enzyme induction. However, no dose adjustment.

    Food does not change the absorption level but only reduces the rate of levetiracetam absorption.

    Cavalry of the drug: Due to no studies on the correspondence of the drug, not mixing this drug with other drugs.

    Storage

    Store in closed packaging, dry place. The temperature does not exceed 30ºC.

    Other drugs

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    count views

    Popular Keywords